I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Freilich, Bradley
53
results:
Search for persons
X
Format
Online (53)
Mediatypes
Articles (Online) (36)
OpenAccess-fulltext (17)
Sorted by: Relevance
Sorted by: Year
?
1
LBO-006 A prospective, blinded, multicenter U.S. evaluation..:
Taggart, David
;
Mahajan, Shivani
;
Gallant, Maxime
...
Journal of Hepatology. 80 (2024) - p. S11 , 2024
Link:
https://doi.org/10.1016/..
?
2
A randomized, double-blind, placebo-controlled trial of ald..:
Rinella, Mary E.
;
Lieu, Hsiao D.
;
Kowdley, Kris V.
...
Hepatology. 79 (2023) 3 - p. 674-689 , 2023
Link:
https://doi.org/10.1097/..
?
3
A randomized, double-blind, placebo-controlled phase IIa tr..:
Harrison, Stephen A.
;
Ruane, Peter J.
;
Freilich, Bradley
...
JHEP Reports. 5 (2023) 1 - p. 100563 , 2023
Link:
https://doi.org/10.1016/..
?
4
Aldafermin in patients with non-alcoholic steatohepatitis (..:
Harrison, Stephen A
;
Abdelmalek, Manal F
;
Neff, Guy
...
The Lancet Gastroenterology & Hepatology. 7 (2022) 7 - p. 603-616 , 2022
Link:
https://doi.org/10.1016/..
?
5
Efx treatment improved histopathology and non-invasive mark..:
Tillman, Erik
;
Shringarpure, Reshma
;
Neff, Guy
...
Journal of Hepatology. 77 (2022) - p. S719 , 2022
Link:
https://doi.org/10.1016/..
?
6
Su1348: EFFICACY, SAFETY, AND TOLERABILITY OF SELADELPAR IN..:
Gordon, Stuart C.
;
Trivedi, Palak
;
Bowlus, Christopher L.
...
Gastroenterology. 162 (2022) 7 - p. S-1191 , 2022
Link:
https://doi.org/10.1016/..
?
7
Redefinition of Fatty Liver Disease from NAFLD to MAFLD thr..:
Fouad, Yasser
;
Palmer, Melissa
;
Chen, Minjun
...
Journal of Clinical and Translational Hepatology. 10 (2021) 2 - p. 374-382 , 2021
Link:
https://doi.org/10.14218..
?
8
Efruxifermin in non-alcoholic steatohepatitis: a randomized..:
Harrison, Stephen A.
;
Ruane, Peter J.
;
Freilich, Bradley L.
...
Nature Medicine. 27 (2021) 7 - p. 1262-1271 , 2021
Link:
https://doi.org/10.1038/..
?
9
Volixibat in adults with non-alcoholic steatohepatitis: 24-..:
Newsome, Philip N.
;
Palmer, Melissa
;
Freilich, Bradley
...
Journal of Hepatology. 73 (2020) 2 - p. 231-240 , 2020
Link:
https://doi.org/10.1016/..
?
10
A randomized, placebo-controlled trial of emricasan in pati..:
Harrison, Stephen A.
;
Goodman, Zachary
;
Jabbar, Abdul
...
Journal of Hepatology. 72 (2020) 5 - p. 816-827 , 2020
Link:
https://doi.org/10.1016/..
?
11
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Non..:
Patel, Keyur
;
Harrison, Stephen A.
;
Elkhashab, Magdy
...
Hepatology. 72 (2020) 1 - p. 58-71 , 2020
Link:
https://doi.org/10.1002/..
?
12
LBP-24-Safety, tolerability and efficacy of volixibat, an a..:
Newsome, Philip
;
Palmer, Melissa
;
Freilich, Bradley
...
Journal of Hepatology. 70 (2019) 1 - p. e152-e153 , 2019
Link:
https://doi.org/10.1016/..
?
13
CONTROL: A randomized phase 2 study of obeticholic acid and..:
Pockros, Paul J.
;
Fuchs, Michael
;
Freilich, Bradley
...
Liver International. 39 (2019) 11 - p. 2082-2093 , 2019
Link:
https://doi.org/10.1111/..
?
14
Su1541 - Responsiveness of Controlled Attenuation Parameter..:
Noureddin, Mazen
;
Kayali, Zeid
;
Harrison, Stephen A.
...
Gastroenterology. 154 (2018) 6 - p. S-1172-S-1173 , 2018
Link:
https://doi.org/10.1016/..
?
15
An Open-Label, Multicenter, Phase I, Dose Escalation Study ..:
El Dika, Imane
;
Lim, Ho Yeong
;
Yong, Wei Peng
...
The Oncologist. 24 (2018) 6 - p. 747-e218 , 2018
Link:
https://doi.org/10.1634/..
1-15
